RHABDOID TUMOUR OF THE KIDNEY

RHABDOID TUMOUR OF THE KIDNEY was reported 11 times

RHABDOID TUMOUR OF THE KIDNEY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Topoisomerase Inhibitor [EPC] 3 0.0000
1 Alkylating Drug [EPC] 3 0.0000
2 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
3 Platinum-based Drug [EPC] 3 0.0000
4 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
5 Interferon beta [EPC] 2 0.0000
6 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
7 Factor Xa Inhibitor [EPC] 1 0.0000
8 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
9 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
10 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
11 Loop Diuretic [EPC] 1 0.0000
12 Kinase Inhibitor [EPC] 1 0.0000
13 Benzodiazepine [EPC] 1 0.0000
14 Corticosteroid [EPC] 1 0.0000
15 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000